Dr. Jennifer Mary Avallone is a King Of Prussia, Pennsylvania based neurologist who is specialized in Epilepsy Treatment. Her current practice location is 550 S Goddard Blvd, King Of Prussia. Patients can reach her at 215-590-1719. Dr. Jennifer Mary Avallone is DO in Epilepsy Treatment and her NPI number (Unique professional ID assigned by NPPES) is 1588800429. Dr. Jennifer Mary Avallone is focused on the diagnosis and treatment of patients with epilepsy, including new-onset, medically refractory epilepsy, psychogenic nonepileptic seizures, and epilepsy in special populations (the elderly, women, patients with co-morbidities). Epilepsy is a multidisciplinary field that provides comprehensive care of the patient.
Complete Profile:
Dr. Jennifer Mary Avallone speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Dr. Jennifer Mary Avallone
Specialization:
Epilepsy Treatment
Gender:
Female
Credentials:
DO
Practice Address:
550 S Goddard Blvd, King Of Prussia, Pennsylvania, 19406-2922
Phone:
215-590-1719
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1588800429
NPI Enumeration Date:
24 Dec, 2008
NPI Last Update On:
07 Mar, 2022
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Jennifer Mary Avallone 550 S Goddard Blvd, King Of Prussia, Pennsylvania
Zip:
19406-2922
Phone Number:
215-590-1719
Patients can reach Dr. Jennifer Mary Avallone at 550 S Goddard Blvd, King Of Prussia, Pennsylvania or can call to book an appointment on 215-590-1719.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.